Erratum to Increased cyclin-dependent kinase 6 expression in bladder cancer (Oncology Letters (2012), 4, (43-46),10.3892/ol.2012.695);Increased cyclin-dependent kinase 6 expression in bladder cancer

Oncology Letters

Volumn 4, Issue 1, 2012, Pages 43-46

  Wang, Gang ^a   Zheng, Lingyan ^b   Yu, Zhijian ^a   Liao, Guodong ^a   Lu, Liqin ^c   Xu, Rujun ^a   Zhao, Zhongsheng ^c   Chen, Guangdi ^d  

^a The First Hangzhou People Hospital   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^d ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Bladder cancer; Cyclin dependent kinase 6; Immunohistochemistry; Tissue microarray

Indexed keywords

CYCLIN DEPENDENT KINASE 6;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; CYTOPLASM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROTEIN EXPRESSION; TRANSITIONAL CELL CARCINOMA;

EID: 84861306587     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1309     Document Type: Erratum

References (19)

1. Siegel R, Ward E, Brawley O and Jemal A: Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61: 212-236, 2011.
2. Kaufman DS, Shipley WU and Feldman AS: Bladder cancer. Lancet 374: 239-249, 2009.
3. Pryor WA: Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity. Environ Health Perspect 105 (Suppl 4): 875-882, 1997.
4. Franekova M, Halasova E, Bukovska E, et al: Gene polymorphisms in bladder cancer. Urol Oncol 26: 1-8, 2008.
5. Murray AW: Recycling the cell cycle: cyclins revisited. Cell 116: 221-234, 2004.
6. Santamaria D and Ortega S: Cyclins and CDKS in development and cancer: lessons from genetically modified mice. Front Biosci 11: 1164-1188, 2006.
7. Meyerson M and Harlow E: Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol Cell Biol 14: 2077-2086, 1994.
8. Lee KH, Lotterman C, Karikari C, et al: Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer. Pancreatology 9: 293-301, 2009.
9. Chilosi M, Doglioni C, Yan Z, et al: Differential expression of cyclin-dependent kinase 6 in cortical thymocytes and T-cell lymphoblastic lymphoma/leukemia. Am J Pathol 152: 209-217, 1998.
10. Costello JF, Plass C, Arap W, et al: Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA. Cancer Res 57: 1250-1254, 1997.
11. Mendrzyk F, Radlwimmer B, Joos S, et al: Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma. J Clin Oncol 23: 8853-8862, 2005.
12. Raspollini MR, Nesi G, Baroni G, et al: p16(INK4a) expression in urinary bladder carcinoma. Arch Ital Urol Androl 78: 97-100, 2006.
13. Shariat SF, Tokunaga H, Zhou J, et al: P53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer. J Clin Oncol 22: 1014-1024, 2004.
14. Chen G, Cheng Y, Zhang Z, et al: Prognostic significance of cytoplasmic p27 expression in human melanoma. Cancer Epidemiol Biomarkers Prev 20: 2212-2221, 2011.
15. Remmele W and Stegner HE: Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8: 138-140, 1987 (In German).
16. Rodriguez-Otero P, Roman-Gomez J, Vilas-Zornoza A, et al: Deregulation of FGFR1 and CDK6 oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the MIR9 family. Br J Haematol 155: 73-83, 2011.
17. Russo AA, Tong L, Lee JO, et al: Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a. Nature 395: 237-243, 1998.
18. Eissa S, Ahmed MI, Said H, et al: Cell cycle regulators in bladder cancer: relationship to schistosomiasis. IUBMB Life 56: 557-564, 2004.
19. Osman HG, Abadeer NY, Mohamed SE and Fahmy AK: Expression of p16, p15 and Cyclin D1 in bladder cancer and correlation with cancer progression. Internet J Urol 4: http://www.ispub.com/journal/the-internet-journal-of-urology/volume-4-number-2/expression-of-p16-p15-and-cyclin-d1-in-bladder-cancer-and-correlates-with-cancer-progression-and-clinical-out-come.html.